Article ID Journal Published Year Pages File Type
3992366 Journal of Thoracic Oncology 2009 6 Pages PDF
Abstract
These observations support a role for the combination of a histone deacetylase inhibitor and a TKI in the treatment of NSCLCs.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
Authors
, , , , , , ,